Brett Zbar

Managing Director and Global Head of Life Sciences

New York City, New York, United States

73 investments

Brett Zbar is a Managing Director and Global Head of Life Sciences at General Atlantic based in New York City, New York, United States. Brett Zbar has backed 73 companies, including AveXis, Remix Therapeutics and Karyopharm Therapeutics. Investment focus areas include Health Care, Talent Management and Hospitals.

Portfolio Companies (74)


1	AveXis
2	Remix Therapeutics
3	Karyopharm Therapeutics
4	Olema Oncology
5	Jounce Therapeutics
6	Wave Life Sciences
7	LifeMine Therapeutics
8	Peloton Therapeutics
9	10X Genomics
10	Ardelyx
11	Adaptimmune
12	Cullinan Oncology

Showing 1–12 of 74

Page 1 of 7

Access Full Contact Information

Get Brett Zbar's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.

Portfolio

3-day free trial, cancel anytime

Raising a round? Run your numbers first

Free tools founders use before pitching investors like this one.

Runway calculatorHow long your cash lasts Burn rate calculatorMonthly spend, gross and net Funding goal calculatorHow much to raise Investor ROI calculatorWhat your investors earn Pitch deck template11 slides that close Fundraising playbookThe 7-step raise process

Brett Zbar

Investment Focus

Portfolio Companies (74)

Access Full Contact Information

Raising a round? Run your numbers first